Treat Canine Osteoarthritis (OA) the Galliprant® (grapiprant tablets) Way

Treat canine osteoarthritis (OA) pain and inflammation with confidence through every stage of OA and help dogs enjoy moments that matter with their families.

2020 Galliprant DanRossPhoto Head Scratch Rossi 0942

Helping Dogs Enjoy Healthy, Comfortable Lives

Unfortunately, too many dogs are suffering in silence with unrecognized or untreated canine osteoarthritis (OA). To provide the highest quality of care, it’s time to evolve the approach to recognizing, diagnosing and managing canine OA through early intervention and treatment.

  • Progressive

    Canine OA is a progressive disease, and signs of pain may be subtle or overlooked

  • Conformational

    Canine OA is often conformational in nature and can affect young dogs, so early detection and diagnosis is key1

  • Treatment

    Start multimodal treatment of OA as soon as the dog is diagnosed

Canine OA is the most common cause of chronic pain in dogs, affecting 1 in 4 adult dogs in the US.2

1 in 4 dogs Galliprant dog image 8.14

Early signs of OA can be hard to distinguish, leading to delayed diagnosis and chronic pain later in life.

The Condition

2020 Galliprant DanRossPhoto Outdoor 3 Fluke 1629

Canine OA, the most common cause of chronic pain in dogs3, is often conformational in nature so it can develop at a young age.1

Learn about the Condition

Stages & Etiology

2020 Galliprant DanRossPhoto Shadowday Hallway 1371

Canine OA is a progressive disease. It can affect dogs during any stage of life, interrupting the special moments shared with their owners.

Learn about the Stages

Symptoms & Diagnosis

2020 Galliprant DanRossPhoto Shadowday Exam 1 2022

Recognizing the signs of OA and engaging the pet owner throughout the process will help you diagnose accurately and early, so you can provide high-quality care to your patients.

Learn about the Signs

Treatment

7d-hands-pouring-meds-Gal-727 x 417

A multimodal treatment approach begins with pain management using an NSAID.

Treating Canine OA

Watch Inspiring Stories

7f-owner-and-dog-on-vet-table-Gal-727 x 417

Experience the joy of providing effective canine OA pain relief and improving the lives of patients.

Watch Inspiring Stories

Indication

Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.

Contact your Elanco or distributor representative, or call Elanco (1-888-545-5973) to discover how you can incorporate Galliprant into your canine OA protocol today.


Connect with Galliprant

Let’s keep in touch


© 2020 Elanco or its affiliates. Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

PM-US-19-1925(2)